Author

B.H. Lee

Sapience TherapeuticsPrimary ORCID profile (0009-0006-4927-0273 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

B.H. LeeiD1 paper · Korea Bioinformation Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abi Vainstein‐Haras· 1 shared Barry J. KappeliD· 1 shared Claudio ScuoppoiD· 1 shared Erin GallagheriD· 1 shared Franco Abbate· 1 shared Gene MerutkaiD· 1 shared Jimmy A. RotoloiD· 1 shared Julia Diehl· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abi Vainstein‐Haras

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synergistic anti-tumor activity of EGFR inhibition and C/EBPβ antagonism in GBM.

Julia Diehl, Claudio Scuoppo, Rick Ramirez, Mark Koester, Siok F. Leong, Zachary F. Mattes, Erin Gallagher, B.H. Lee, Franco Abbate, Lila Ghamsari, Gene Merutka, Abi Vainstein‐Haras, Barry J. Kappel, Jimmy A. Rotolo

This study shows that combining EGFR inhibition with C/EBPβ antagonism enhances anti-tumor activity in GBM, based on in vitro and in vivo experiments and clinical data.

bioRxiv · Apr 21, 2026 · PreprintCancer Biology